Literature DB >> 20383141

Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis.

Szu-Wei Lee1,2, Chien-Feng Li3, Chia-Hsin Chan1, Jing Wang1, Wei-Lei Yang1,2, Ching-Yuan Wu1,4,5, Juan Wu1,6, Keiichi I Nakayama7, Hong-Yo Kang5, Hsuan-Ying Huang8, Mien-Chie Hung1,2,9, Pier Paolo Pandolfi10, Hui-Kuan Lin1,2.   

Abstract

The RhoA GTPase is crucial in numerous biological functions and is linked to cancer metastasis. However, the understanding of the molecular mechanism responsible for RhoA transcription is still very limited. Here we show that RhoA transcription is orchestrated by the Myc-Skp2-Miz1-p300 transcriptional complex. Skp2 cooperates with Myc to induce RhoA transcription by recruiting Miz1 and p300 to the RhoA promoter independently of Skp1-Cullin-F-box protein containing complex (SCF)-Skp2 E3 ligase activity. Deficiency of this complex results in impairment in RhoA expression, cell migration, invasion, and breast cancer metastasis, recapitulating the phenotypes observed in RhoA knockdown, and RhoA restoration rescues the defect in cell invasion. Overexpression of the Myc-Skp2-Miz1 complex is found in metastatic human cancers and is correlated with RhoA expression. Our study provides insight into how oncogenic Skp2 and Myc coordinate to induce RhoA transcription and establishes a novel SCF-Skp2 E3-ligase-independent function for oncogenic Skp2 in transcription and cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383141      PMCID: PMC3855841          DOI: 10.1038/ncb2047

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  44 in total

1.  Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4.

Authors:  P Kaiser; K Flick; C Wittenberg; S I Reed
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

Review 2.  Transcriptional repression by Myc.

Authors:  Michael Wanzel; Steffi Herold; Martin Eilers
Journal:  Trends Cell Biol       Date:  2003-03       Impact factor: 20.808

3.  Skp2 regulates Myc protein stability and activity.

Authors:  So Young Kim; Andreas Herbst; Kathryn A Tworkowski; Simone E Salghetti; William P Tansey
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

4.  Repression of p15INK4b expression by Myc through association with Miz-1.

Authors:  P Staller; K Peukert; A Kiermaier; J Seoane; J Lukas; H Karsunky; T Möröy; J Bartek; J Massagué; F Hänel; M Eilers
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

5.  Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.

Authors:  Hui-Kuan Lin; Guocan Wang; Zhenbang Chen; Julie Teruya-Feldstein; Yan Liu; Chia-Hsin Chan; Wei-Lei Yang; Hediye Erdjument-Bromage; Keiichi I Nakayama; Stephen Nimer; Paul Tempst; Pier Paolo Pandolfi
Journal:  Nat Cell Biol       Date:  2009-03-08       Impact factor: 28.824

6.  The E3 ligase TRAF6 regulates Akt ubiquitination and activation.

Authors:  Wei-Lei Yang; Jing Wang; Chia-Hsin Chan; Szu-Wei Lee; Alejandro D Campos; Betty Lamothe; Lana Hur; Brian C Grabiner; Xin Lin; Bryant G Darnay; Hui-Kuan Lin
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

Review 7.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

8.  A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth.

Authors:  Michael Wanzel; Annika C Russ; Daniela Kleine-Kohlbrecher; Emanuela Colombo; Pier-Guiseppe Pelicci; Martin Eilers
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

9.  Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

Authors:  Yadi Wu; Jiong Deng; Piotr G Rychahou; Suimin Qiu; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2009-05-05       Impact factor: 31.743

10.  A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

Authors:  Scott Valastyan; Ferenc Reinhardt; Nathan Benaich; Diana Calogrias; Attila M Szász; Zhigang C Wang; Jane E Brock; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  122 in total

1.  Transcriptional regulation of Rho GTPase signaling.

Authors:  Daniel R Croft; Michael F Olson
Journal:  Transcription       Date:  2011 Sep-Oct

2.  p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival.

Authors:  Daniel R Croft; Diane Crighton; Michael S Samuel; Filipe C Lourenco; June Munro; Jenifer Wood; Karim Bensaad; Karen H Vousden; Owen J Sansom; Kevin M Ryan; Michael F Olson
Journal:  Cell Res       Date:  2010-11-16       Impact factor: 25.617

3.  Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases.

Authors:  Xun Shang; Fillipo Marchioni; Nisha Sipes; Chris R Evelyn; Moran Jerabek-Willemsen; Stefan Duhr; William Seibel; Matthew Wortman; Yi Zheng
Journal:  Chem Biol       Date:  2012-06-22

4.  Skp2 is required for Aurora B activation in cell mitosis and spindle checkpoint.

Authors:  Juan Wu; Yu-Fan Huang; Xin-Ke Zhou; Wei Zhang; Yi-Fan Lian; Xiao-Bin Lv; Xiu-Rong Gao; Hui-Kuan Lin; Yi-Xin Zeng; Jian-Qing Huang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Authors:  Xiao-Xin Sun; Rosalie C Sears; Mu-Shui Dai
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.

Authors:  J Wu; S-W Lee; X Zhang; F Han; S-Y Kwan; X Yuan; W-L Yang; Y S Jeong; A H Rezaeian; Y Gao; Y-X Zeng; H-K Lin
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

7.  Rapamycin resistance is linked to defective regulation of Skp2.

Authors:  Hana Totary-Jain; Despina Sanoudou; Cula N Dautriche; Hillary Schneller; Lester Zambrana; Andrew R Marks
Journal:  Cancer Res       Date:  2012-02-06       Impact factor: 12.701

8.  SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.

Authors:  Yu-Feng Tian; Tzu-Ju Chen; Ching-Yih Lin; Li-Tzong Chen; Li-Ching Lin; Chung-Hsi Hsing; Sung-Wei Lee; Ming-Jen Sheu; Hao-Hsien Lee; Yow-Ling Shiue; Hsuan-Ying Huang; Hsin-Yi Pan; Chien-Feng Li; Shang-Hung Chen
Journal:  Tumour Biol       Date:  2013-01-18

9.  Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.

Authors:  Sreeharsha Gurrapu; Emanuela Pupo; Giulia Franzolin; Letizia Lanzetti; Luca Tamagnone
Journal:  Cell Death Differ       Date:  2018-03-19       Impact factor: 15.828

10.  Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.

Authors:  Zheng Wei; Xian Jiang; Fengjun Liu; Haiquan Qiao; Baoguo Zhou; Bo Zhai; Lianfeng Zhang; Xuwen Zhang; Likun Han; Hongchi Jiang; Geoffrey W Krissansen; Xueying Sun
Journal:  Tumour Biol       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.